Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

NCT00056641 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: tipranavir
DRUG: ritonavir
DRUG: saquinavir
DRUG: amprenavir
DRUG: lopinavir

Sponsor

Boehringer Ingelheim